Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

David Loran

Thoracic Surgery (Cardiothoracic Vascular Surgery) Harrisburg, PA Medical Doctor

NPI 1215980677 CMS profile 55716

205 S Front St, 4Th Fl Bma, Harrisburg, PA 17104

Open in the dashboard

General payments

$105,657

251 records reported · program years 2019–2025

Research payments

$2,000

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$104,016 paid to institutions, not to them · program years 2019–2025

Through program year 2025, David Loran of Harrisburg, PA is reported in the CMS Open Payments database as having received $105,657 across 251 general payments and $2,000 in research payments paid to them. Separately, studies naming them as principal investigator received $104,016 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 94th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,529 23
2024 General $9,993 35
2023 General $15,716 45
2022 General $21,053 41
2021 General $10,888 29
2020 General $19,948 28
2020 Research $2,000 1
2019 General $23,530 50

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Loran
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to David Loran were reported at $4,529. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year David Loran Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $23,530 $886 $178–$3,167 $163
2020 $19,948 $341 $108–$1,605 $114
2021 $10,888 $453 $125–$1,886 $132
2022 $21,053 $695 $180–$2,566 $149
2023 $15,716 $745 $205–$2,662 $160
2024 $9,993 $799 $214–$2,967 $164
2025 $4,529 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $57,838 103 payments
  2. Medtronic Vascular, Inc. $42,728 63 payments
  3. Atricure, Inc. $3,074 64 payments
  4. CryoLife, Inc. $633 3 payments
  5. Silk Road Medical, Inc. $310 2 payments
  6. Philips Electronics North America Corporation $271 4 payments
  7. Shockwave Medical, Inc $157 2 payments
  8. Edwards Lifesciences Corporation $139 1 payment
  9. Corcym Inc $117 1 payment
  10. Janssen Pharmaceuticals, Inc $96 1 payment
  11. Other $293 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $89,475 35 payments
  2. Food and Beverage $10,319 194 payments
  3. Travel and Lodging $5,113 21 payments
  4. Consulting Fee $750 1 payment
Products named General payments · program years 2019–2025
  1. COREVALVE EVOLUT R $27,718 17 payments
  2. Valiant Navion Aortic Stent Grafts $20,787 17 payments
  3. ENDURANT IIS $12,684 44 payments
  4. CoreValve Evolut Transcatheter Valve Systems $12,431 13 payments
  5. Endurant Aortic Stent Grafts $7,004 15 payments
  6. Valiant Captivia $6,682 8 payments
  7. Endurant Aortic Stent Grafts $5,989 23 payments
  8. CoreValve Evolut Transcatheter Valve Systems $1,598 2 payments
  9. Valiant Navion Aortic Stent Grafts $1,500 1 payment
  10. ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) $861 16 payments
  11. Other $5,942 98 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic Vascular, Inc. $2,000 1 payment

Billing to Medicare

Part B · data year 2024 · 91 billing codes

Paid by Medicare

$173,065

Medicare's payments for the services billed

Medicare patients

454

Average age 75

Services billed

697

204 women, 250 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 69%
Heart failure 56%
Chronic kidney disease 54%
Arthritis 53%
Diabetes 52%
Atrial fibrillation 42%
COPD 30%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

252 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record